New diabetes clinical trial: Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes
Published on: November 15, 2022 at 11:00AM
Conditions: Type 1 Diabetes; Hypoglycemia
Interventions: Other: Mixed Meal Tolerance Test (MMTT); Other: Arginine Stimulation Test (AST); Other: Light Mixed Meal Tolerance Test (Light MMTT) OR Repeat AST
Sponsors: University of Exeter; Royal Devon and Exeter NHS Foundation Trust
Not yet recruiting
https://ift.tt/qkUXAhi
Conditions: Type 1 Diabetes; Hypoglycemia
Interventions: Other: Mixed Meal Tolerance Test (MMTT); Other: Arginine Stimulation Test (AST); Other: Light Mixed Meal Tolerance Test (Light MMTT) OR Repeat AST
Sponsors: University of Exeter; Royal Devon and Exeter NHS Foundation Trust
Not yet recruiting
https://ift.tt/qkUXAhi
Comments
Post a Comment